Literature DB >> 23027529

Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection.

Carey E Connelly1, Yezhou Sun, Nicholas H Carbonetti.   

Abstract

Throughout infection, pathogenic bacteria induce dramatic changes in host transcriptional repertoires. An understanding of how bacterial factors influence host reprogramming will provide insight into disease pathogenesis. In the human respiratory pathogen Bordetella pertussis, the causative agent of whooping cough, pertussis toxin (PT) is a key virulence factor that promotes colonization, suppresses innate immune responses during early infection, and causes systemic disease symptoms. To determine the full extent of PT-associated gene regulation in the airways through the peak of infection, we measured global transcriptional profiles in the lungs of BALB/c mice infected with wild-type (WT) or PT-deficient (ΔPT) B. pertussis. ΔPT bacteria were inoculated at a dose equivalent to the WT dose and at a high dose (ΔPT(high)) to distinguish effects caused by higher bacterial loads achieved in WT infection from effects associated with PT. The results demonstrated that PT was associated with a significant upregulation of immune and inflammatory response genes as well as several other genes implicated in airway pathology. In contrast to the early, transient responses observed for ΔPT(high) infection, WT infection induced a prolonged expression of inflammatory genes and increased the extent and duration of lung histopathology. In addition, the administration of purified PT to ΔPT(high)-infected mice 1 day after bacterial inoculation exacerbated and prolonged inflammatory responses and airway pathology. These data indicate that PT not only is associated with exacerbated host airway responses during peak B. pertussis infection but also may inhibit host mechanisms of attenuating and resolving inflammation in the airways, suggesting possible links between PT and pertussis disease symptoms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23027529      PMCID: PMC3497438          DOI: 10.1128/IAI.00808-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  91 in total

1.  4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells.

Authors:  Young H Kim; Beom K Choi; Su M Shin; Chang H Kim; Ho S Oh; Sang H Park; Don G Lee; Myoung J Lee; Kwang H Kim; Dass S Vinay; Byoung S Kwon
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

2.  Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin.

Authors:  G J Spangrude; F Sacchi; H R Hill; D E Van Epps; R A Daynes
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

3.  Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins.

Authors:  N Khelef; C M Bachelet; B B Vargaftig; N Guiso
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

4.  Reduced pulmonary function is associated with enhanced inflammation and tissue inhibitor of metalloproteinase 1 concentration in the bronchoalveolar lavage fluid of patients with lung parenchymal sarcoidosis.

Authors:  Akiko Shimada; Takeharu Koga; Yuichi Oshita; Mikiko Hanada; Yoshiro Nagafuchi; Hisamichi Aizawa
Journal:  Kurume Med J       Date:  2008

5.  Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice.

Authors:  Charlotte Andreasen; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

Review 6.  Pulmonary arterial hypertension complicating connective tissue diseases.

Authors:  Paul M Hassoun
Journal:  Semin Respir Crit Care Med       Date:  2009-07-24       Impact factor: 3.119

7.  Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.

Authors:  Andrew D Rowan; Wang Hui; Tim E Cawston; Carl D Richards
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

8.  Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells.

Authors:  Xin Chen; Robin T Winkler-Pickett; Nicholas H Carbonetti; John R Ortaldo; Joost J Oppenheim; O M Zack Howard
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

9.  Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.

Authors:  Daniel J Angelini; Qingning Su; Kazuyo Yamaji-Kegan; Chunling Fan; Xingwu Teng; Paul M Hassoun; Stephen C Yang; Hunter C Champion; Rubin M Tuder; Roger A Johns
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-27       Impact factor: 6.914

10.  Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.

Authors:  Frits R Mooi; Inge H M van Loo; Marjolein van Gent; Qiushui He; Marieke J Bart; Kees J Heuvelman; Sabine C de Greeff; Dimitri Diavatopoulos; Peter Teunis; Nico Nagelkerke; Jussi Mertsola
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more
  38 in total

1.  Peptidoglycan Recognition Protein 4 Suppresses Early Inflammatory Responses to Bordetella pertussis and Contributes to Sphingosine-1-Phosphate Receptor Agonist-Mediated Disease Attenuation.

Authors:  Ciaran Skerry; William E Goldman; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

2.  Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection.

Authors:  Karen M Scanlon; Yael Gau; Jingsong Zhu; Ciaran Skerry; Susan M Wall; Manoocher Soleimani; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

Review 3.  Pertussis pathogenesis--what we know and what we don't know.

Authors:  Erik L Hewlett; Drusilla L Burns; Peggy A Cotter; Eric T Harvill; Tod J Merkel; Conrad P Quinn; E Scott Stibitz
Journal:  J Infect Dis       Date:  2014-04-01       Impact factor: 5.226

4.  Intracellular disassembly and activity of pertussis toxin require interaction with ATP.

Authors:  Roger D Plaut; Karen M Scanlon; Michael Taylor; Ken Teter; Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-06-30       Impact factor: 3.166

Review 5.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

Review 6.  Contribution of pertussis toxin to the pathogenesis of pertussis disease.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

Review 7.  Novel therapies for the treatment of pertussis disease.

Authors:  Karen M Scanlon; Ciaran Skerry; Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

8.  Fatal Pertussis in the Neonatal Mouse Model Is Associated with Pertussis Toxin-Mediated Pathology beyond the Airways.

Authors:  Karen M Scanlon; Yael G Snyder; Ciaran Skerry; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

9.  Pendrin, an anion exchanger on lung epithelial cells, could be a novel target for lipopolysaccharide-induced acute lung injury mice.

Authors:  Chun-E Jia; Dingyuan Jiang; Huaping Dai; Fei Xiao; Chen Wang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

10.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.